The allogeneic dilemma-Reference-Cited by-同舟云学术

The allogeneic dilemma

Published:2007-08-06 Issue:12 Volume:40 Page:1123-1128
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Harousseau J-L

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705810.pdf

Reference45 articles.

1. Corradini P, Voena C, Tarella C, Astolfi M, Ladetto M, Palumbo A et al. Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. J Clin Oncol 1999; 17: 208–215.

2. Gahrton G, Tura S, Ljungman P, Blade J, Brandt L, Cavo M et al. Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. J Clin Oncol 1995; 13: 1312–1322.

3. Bensinger WI, Buckner CD, Anasetti C, Clift R, Storb R, Barnett T et al. Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome. Blood 1996; 88: 2787–2793.

4. Mehta J . Allogeneic hematopoietic stem cell transplantation in myeloma. In: Mehta J, Singhal S (eds). Myeloma Editions. Martin Dunitz: London, 2002; pp 349–365.

5. Bjorkstrand BB, Ljungman P, Svensson H, Hermans J, Alegre A, Apperley J et al. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation. Blood 1996; 88: 4711–4718.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adoptive cell therapy in multiple Myeloma;Expert Opinion on Biological Therapy;2017-09-06

2. In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review;Bone Marrow Transplantation;2017-07-10

3. Clinical impact of sarcopenia and relevance of nutritional intake in patients before and after allogeneic hematopoietic stem cell transplantation;Journal of Cancer Research and Clinical Oncology;2017-02-21

4. Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity;Bone Marrow Transplantation;2016-01-04

5. Evolving role of high dose stem cell therapy in multiple myeloma;Indian Journal of Medical and Paediatric Oncology;2011-01